Ingevity (NGVT) CEO David Li sells 10,000 shares under 10b5-1 plan

Rhea-AI Filing Summary

Ingevity Corp President & CEO David H. Li reported open-market sales of company common stock under a Rule 10b5-1 trading plan. He sold 5,000 shares on August 12, 2026 at a weighted average price of $76.62 and 5,000 shares on August 13, 2026 at a weighted average price of $75.73, each executed through multiple trades within disclosed price ranges.

Insider Trade Summary 10b5-1

Net Seller: 10,000 shares

Net Sell 2 txns

Insider Li David H

Role President & CEO

Sold 10,000 shs ($762K)

Type	Security	Shares	Price	Value
Sale	Common Stock F2	5,000	$75.73	$379K
Sale	Common Stock F1	5,000	$76.62	$383K

Holdings After Transaction: Common Stock — 130,636 shares (Direct)

Footnotes (2)

1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.14 to $78.22, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.18 to $76.26, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Total shares sold: 10,000 shares Weighted average sale price 12-Aug-2026: $76.62 per share Price range 12-Aug-2026: $76.14–$78.22 +2 more

5 metrics

Total shares sold 10,000 shares Common stock sold by President & CEO David H. Li over August 12–13, 2026

Weighted average sale price 12-Aug-2026 $76.62 per share 5,000 shares of common stock sold in multiple transactions

Price range 12-Aug-2026 $76.14–$78.22 Range of execution prices for shares sold on August 12, 2026

Weighted average sale price 13-Aug-2026 $75.73 per share 5,000 shares of common stock sold in multiple transactions

Price range 13-Aug-2026 $75.18–$76.26 Range of execution prices for shares sold on August 13, 2026

Key Terms

Rule 10b5-1 trading plan, weighted average price, open market or private transaction

3 terms

Rule 10b5-1 trading plan regulatory

"transactions were conducted under a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market or private transaction financial

"transaction_code_description: Sale in open market or private transaction"

FAQ

What insider transaction did Ingevity (NGVT) report in this Form 4?

Ingevity President & CEO David H. Li reported selling 10,000 shares of common stock in two open-market transactions on August 12–13, 2026, executed at disclosed weighted average prices.

At what prices did the NGVT CEO sell shares in August 2026?

David H. Li sold 5,000 shares at a weighted average price of $76.62 and another 5,000 shares at a weighted average price of $75.73, each representing multiple trades within specified price ranges.

How many Ingevity (NGVT) shares did the CEO sell in total?

The CEO sold a total of 10,000 shares of Ingevity common stock, split into two blocks of 5,000 shares each, recorded as separate open-market sale transactions on consecutive days.

Were the NGVT CEO’s August 2026 stock sales under a Rule 10b5-1 plan?

Yes. The filing indicates the transactions were conducted under a Rule 10b5-1 trading plan, meaning the sale instructions were pre-arranged in advance under a written trading program.

What price ranges applied to the NGVT CEO’s August 12, 2026 sale?

For the August 12 sale, the $76.62 weighted average price reflects multiple trades executed between $76.14 and $78.22. Detailed per-trade prices and share amounts are available on request from the company or the filer.

What price ranges applied to the NGVT CEO’s August 13, 2026 sale?

For the August 13 sale, the $75.73 weighted average price reflects multiple trades executed between $75.18 and $76.26. The reporting person offers to provide full breakdowns of shares at each price upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/14/2026 - 05:06 PM Accepted by SEC EDGAR 08/14/2026 - 05:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Li David H

(Last) (First) (Middle)

C/O INGEVITY CORPORATION

4920 O'HEAR AVE, SUITE 400

(Street)

NORTH CHARLESTON SOUTH CAROLINA 29405

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ingevity Corp [ NGVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/12/2026		S		5,000	D	$76.62(1)	135,636	D
Common Stock	08/13/2026		S		5,000	D	$75.73(2)	130,636	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.14 to $78.22, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.18 to $76.26, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	David H. Li By: Mavis G. Huger as Attorney-in-Fact	08/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)